The time to fix the roof is when the sun is shining. -- JFK
There is some genuinely encouraging news about Alzheimer’s disease and dementia. Not because somebody has discovered a miracle drug or a cure, but because scientists are beginning to understand much more about why these diseases develop, what contributes to them, and, most importantly, what we might be able to do to reduce our chances of developing them.
And this subject is personal to me. My mother had Alzheimer’s.
If you have ever had a parent, spouse, or somebody close to you develop this terrible disease, you understand that Alzheimer’s doesn’t just affect the individual. It affects the entire family.
You watch somebody you have known and loved your entire life gradually lose the very abilities that made them who they were. Their memories, their independence, their ability to communicate, and eventually their connection to the world around them.
There is something particularly cruel about a disease that slowly takes away a person’s memories while leaving the people who love them remembering everything.
For years, Alzheimer’s seemed like one of those diseases where the best we could do was hope it wouldn’t happen to us. We blamed aging. We blamed genetics. We looked for medications that might slow it down.
And when somebody received the diagnosis, there wasn’t much anyone could do to change the outcome. But something important is happening in medical research.
Scientists are recognizing that Alzheimer’s and dementia are far more complicated than we once believed. More importantly, a significant portion of dementia risk may be influenced by factors we can actually do something about.
And here is the part I want younger people to understand. You should be thinking about your brain when you’re 30 or 40, not waiting until you’re 70 and beginning to forget things.
THE SCALE OF THE PROBLEM
Before discussing the good news, we need to understand what we’re dealing with.
According to the Alzheimer’s Association’s 2026 report:
Approximately 7.4 million Americans over age 65 are living with Alzheimer’s dementia.
About one in nine Americans aged 65 and older has the disease.
Among Americans aged 85 and older, approximately 36% have Alzheimer’s dementia.
Alzheimer’s was the sixth-leading cause of death in the United States in 2024.
More than 12 million Americans provide unpaid care for people living with Alzheimer’s and other dementias.
And the estimated annual American cost of Alzheimer’s and other dementias is approximately $409 billion in 2026.
Worldwide, approximately 57 million people were living with dementia in 2021, and nearly 10 million new cases occur every year.
Those are staggering numbers.
But the financial costs are only part of the story.
Imagine the millions of families watching somebody they love slowly disappear into a world they can no longer understand.
That is the real tragedy.
And that is why this new research matters so much.
WHAT WE THOUGHT CAUSED ALZHEIMER’S
For decades, much of Alzheimer’s research concentrated on something called beta-amyloid.
Beta-amyloid is a protein fragment that can accumulate in the brain, forming plaques.
Scientists discovered that the brains of Alzheimer’s patients frequently contained these abnormal protein deposits.
Another protein, called tau, can form abnormal tangles inside neurons.
The prevailing theory was that these abnormal proteins damaged brain cells, eventually producing the memory loss and cognitive decline associated with Alzheimer’s.
Consequently, researchers spent billions of dollars trying to develop medications that would remove amyloid from the brain.
That research was not entirely unsuccessful.
We now have medications such as lecanemab and donanemab that remove amyloid and can modestly slow cognitive decline in certain patients with early Alzheimer’s.
But they don’t cure the disease, restore lost memories, or work for everybody.
And there is another interesting problem.
Some people accumulate substantial amyloid deposits without ever developing dementia.
This suggests that amyloid alone does not explain the entire disease.
So researchers are asking a much bigger question.
What is happening inside the brain that allows these destructive processes to develop in the first place?
WHAT SCIENTISTS THINK NOW
One of the most exciting directions in Alzheimer’s research involves metabolism, inflammation, blood circulation, and the brain’s immune system.
Let’s start with metabolism.
Most people hear the word metabolism and think about weight loss.
But metabolism is much more important than that.
Metabolism is how your body’s cells produce and use energy.
Every cell in your body needs energy to function.
Your heart needs energy to pump blood.
Your muscles need energy to move.
And your brain needs an enormous amount of energy to think, remember, communicate, and maintain billions of connections between nerve cells.
The brain is particularly vulnerable when its energy systems stop functioning properly.
Researchers are investigating whether impaired insulin signaling, abnormal glucose metabolism, mitochondrial dysfunction, and chronic inflammation contribute to the development of Alzheimer’s.
Mitochondria are the tiny energy-producing structures inside our cells.
When these systems malfunction, neurons may become less capable of maintaining their normal functions.
Another important area of research involves microglia.
Microglia are immune cells that live inside the brain.
Normally, they help protect the brain, clear cellular debris, and maintain healthy connections between neurons.
But when inflammatory signals become excessive or persistent, microglia can contribute to damage rather than protection.
Researchers are studying whether changes in cellular metabolism help drive these damaging inflammatory responses.
This is important because diabetes, obesity, high blood pressure, physical inactivity, and other metabolic problems are also associated with increased dementia risk.
That doesn’t mean Alzheimer’s is simply diabetes of the brain, as some people have suggested.
It means that metabolism may be one important piece of a much larger biological puzzle.
The emerging picture includes amyloid, tau, inflammation, genetics, metabolic dysfunction, and vascular damage.
We are moving away from the idea that Alzheimer’s has one simple cause.
And that opens the door to many more opportunities for prevention and treatment.
THE BIG QUESTION: IS ALZHEIMER’S PREVENTABLE?
Here comes the really good news. A major 2024 report from the Lancet Commission on dementia prevention examined the scientific evidence surrounding 14 potentially modifiable dementia risk factors.
Its conclusion was remarkable. Approximately 45% of dementia cases could potentially be prevented or delayed by addressing those factors.
Think about that. We are discussing a disease that affects millions of Americans, costs hundreds of billions of dollars, and devastates families.
And researchers believe that addressing known risk factors could substantially reduce the number of people who develop dementia.
Now, let’s be very clear. That 45% is a population-level estimate covering dementia generally, not a guarantee that an individual can eliminate 45% of their Alzheimer’s risk.
And it does not mean every case of Alzheimer’s is preventable.
Aging, genetics, and biological factors beyond our control still matter enormously.
Some people who follow exceptionally healthy lifestyles will still develop Alzheimer’s.
But this research represents a major change in how we should think about brain health.
Instead of waiting until the disease appears and hoping somebody discovers a drug, we can start reducing risk decades earlier.
GENETICS IS NOT NECESSARILY YOUR DESTINY
One of the things that concerns people like me, who have a parent who developed Alzheimer’s, is genetics.
Does having a parent with Alzheimer’s mean you are destined to develop it yourself?
No. Family history can increase your risk, and certain genetic variations, particularly APOE4, are associated with a greater likelihood of developing Alzheimer’s.
But having APOE4 does not guarantee that you will get the disease.
And not having it doesn’t guarantee that you won’t.
The important distinction is between genetic risk and genetic destiny.
Many people with elevated genetic risk never develop Alzheimer’s.
Researchers are finding that lifestyle interventions can improve cognitive health even among people carrying genetic risk factors.
We cannot change the DNA we inherited from our parents.
But we can influence some of the environmental, cardiovascular, and metabolic conditions in which our brains operate.
And that is an encouraging development.
WHY YOU SHOULD START AT 30 OR 40
Here is something that I believe we need to change about how we approach medicine.
We don’t wait until somebody has a heart attack before telling them to monitor cholesterol, manage blood pressure, exercise, and stop smoking.
We begin discussing cardiovascular risk decades before the heart attack happens.
Why shouldn’t we do the same thing with Alzheimer’s?
The biological changes associated with Alzheimer’s can begin many years before noticeable memory problems develop.
By the time somebody starts forgetting familiar names, becoming confused, or having trouble managing everyday activities, significant changes may already have occurred.
That is why prevention needs to start long before symptoms appear.
If you’re 30 or 40, you should already be paying attention to your blood pressure, cholesterol, blood sugar, weight, sleep, physical activity, and overall metabolic health.
Not because you are expecting Alzheimer’s tomorrow.
But because what you do throughout adulthood may influence your brain health decades later.
And one of the most important tools available is remarkably simple.
EXERCISE — PROBABLY THE BEST PLACE TO START
One of the strongest messages in the neurological research I reviewed is the importance of physical activity.
Exercise influences multiple biological systems associated with dementia risk.
It improves insulin sensitivity.
It helps regulate blood sugar.
It improves cardiovascular health.
It supports blood flow to the brain.
It can reduce chronic inflammation.
It improves sleep and mental health.
It also stimulates biological pathways involved in maintaining healthy brain cells and their connections.
And here is something particularly interesting.
Your muscles do more than move your body.
When you exercise, muscles release signaling molecules called myokines.
These molecules can influence other organs, including the brain.
Exercise also supports pathways involving brain-derived neurotrophic factor, or BDNF, a protein important for neuronal health and plasticity.
Both aerobic exercise and strength training appear useful.
You don’t have to become a marathon runner or a bodybuilder.
Walking, cycling, swimming, gardening, lifting weights, or doing regular resistance exercises can all contribute to better health.
A practical starting goal is at least 150 minutes of moderate physical activity every week, along with strength training twice weekly.
And if you spend most of your day sitting, begin by getting up and moving more frequently.
The objective isn’t to become an athlete.
It’s to avoid spending decades allowing your muscles, cardiovascular system, and metabolic health to deteriorate.
THE METFORMIN CONNECTION — ONE OF THE MOST INTERESTING DEVELOPMENTS
Now we come to an especially interesting development.
Metformin.
If you’ve ever dealt with type 2 diabetes, or know somebody who has, you’ve probably heard of this medication.
Metformin has been used for decades to help control blood sugar.
It primarily works by reducing glucose production in the liver and improving aspects of metabolic regulation.
It’s inexpensive, widely available, and extensively studied.
So why are Alzheimer’s researchers interested in a diabetes medication?
Because metabolism and insulin resistance are increasingly recognized as potentially important contributors to brain dysfunction.
Researchers are investigating whether improving these metabolic processes might help protect the brain or slow certain aspects of Alzheimer’s progression.
A preliminary study released in August 2026 examining long-term participants in the Diabetes Prevention Program found an association between assignment to metformin and lower odds of dementia.
The findings were encouraging, but the analysis involved relatively few dementia cases, and it has not yet undergone journal peer review.
It is an interesting signal, not proof that metformin prevents Alzheimer’s.
And now a major British research program is putting metformin to a more rigorous test.
THE NEW BRITISH AD-SMART TRIAL
In October 2026, researchers in the United Kingdom announced the launch of AD-SMART.
This is an innovative clinical trial designed to evaluate multiple potential Alzheimer’s treatments simultaneously.
The initial program aims to enroll approximately 1,200 participants through more than 30 planned National Health Service sites.
The first two medications being tested are:
Metformin, commonly prescribed for type 2 diabetes.
Atomoxetine, a medication normally used to treat ADHD.
The idea is to determine whether medications already approved for other conditions can help people living with Alzheimer’s.
Researchers will compare the treatments against placebo while evaluating memory, thinking, daily functioning, and quality of life.
The trial also uses an adaptive design.
That means researchers can discontinue medications that aren’t showing benefits and introduce additional candidates.
Instead of spending years testing one medication after another, they can investigate several approaches within the same research program.
The initial drug evaluations are expected to conclude around 2030.
The fact that metformin is being studied is exciting.
But there is an important distinction.
Metformin is not currently an approved treatment or preventive medication for Alzheimer’s.
And nobody should start taking it specifically to prevent dementia without discussing the evidence and risks with a qualified physician.
It can cause side effects, including gastrointestinal problems and vitamin B12 deficiency, and it is not suitable for some patients with kidney disease.
Still, this research represents an interesting shift.
Scientists are testing treatments aimed at biological processes beyond amyloid plaques.
And that gives us additional avenues to explore.
ANOTHER IMPORTANT STUDY — U.S. POINTER
While researchers investigate new medications, another study has produced encouraging results using something much more familiar.
Lifestyle changes.
The Alzheimer’s Association’s U.S. POINTER study involved 2,111 older adults at increased risk of cognitive decline.
The researchers investigated whether programs combining exercise, better nutrition, mental stimulation, social engagement, and cardiovascular monitoring could improve cognitive function.
Results published in July 2025 showed improvements in cognition in both intervention groups.
Participants who received a more structured program with regular support and accountability experienced greater benefits.
Now, this study did not prove that the interventions prevented Alzheimer’s.
Researchers still need longer follow-up to determine whether they reduce dementia diagnoses.
But it demonstrated something very important.
Coordinated lifestyle interventions can produce measurable improvements in cognitive performance.
And those improvements were observed across different genetic risk groups.
For those of us with a family history of Alzheimer’s, that is encouraging news.
YOUR SOCIAL LIFE MATTERS TOO
One of the more surprising findings in dementia research concerns loneliness and social isolation.
Human beings are social creatures.
Our brains evolved in an environment where communication, cooperation, relationships, and community were essential to survival.
Research has found that social isolation is associated with increased dementia risk.
Why?
Scientists are still investigating the exact mechanisms.
Possible explanations involve chronic stress, depression, reduced cognitive stimulation, inflammation, and changes in overall physical health.
But the practical implications are relatively straightforward.
Maintaining friendships, participating in community activities, spending time with family, volunteering, and continuing to interact with other people may support long-term brain health.
Your brain needs stimulation.
And sometimes the best stimulation comes from other people.
You can have excellent blood sugar, normal cholesterol, and a perfectly healthy diet, but that doesn’t mean you should spend the next 30 years sitting alone watching television.
Human connections matter.
WHAT ABOUT SLEEP AND DIET?
Sleep is another area receiving growing attention.
During sleep, the brain performs essential maintenance processes.
Sleep is involved in memory consolidation, metabolic regulation, and systems that help clear waste products from brain tissue.
Poor sleep, particularly when associated with untreated sleep apnea, may contribute to cognitive problems.
Most adults should aim for approximately seven to nine hours of sleep.
If you snore heavily, repeatedly stop breathing while sleeping, or experience severe daytime sleepiness, you should consider being evaluated for sleep apnea.
Diet matters as well.
Research has found associations between healthier dietary patterns and better cognitive outcomes.
The Mediterranean and MIND dietary patterns emphasize vegetables, leafy greens, berries, beans, whole grains, nuts, olive oil, and fish.
They also encourage limiting excessive saturated fat, highly processed foods, and added sugars.
The goal isn’t to follow some fashionable diet promoted by an internet influencer.
It’s to maintain good metabolic and cardiovascular health over a lifetime.
And remember that controlling diabetes, high blood pressure, and elevated cholesterol may be just as important as buying organic vegetables or taking expensive supplements.
THE BRAIN HEALTH CHECKLIST
Here is a practical checklist based on the major risk factors identified by dementia researchers, along with additional habits that support general brain health.
Go through it honestly.
You don’t need to be perfect.
But the more problems you can identify and address, the better positioned you may be to protect your long-term cognitive health.
□ PHYSICAL INACTIVITY — Do I spend most of the day sitting, with little walking or exercise? Start moving regularly and aim for at least 150 minutes of moderate activity weekly.
□ MUSCLE LOSS — Am I maintaining my strength as I age? Include resistance or strength training at least twice a week.
□ HIGH BLOOD SUGAR — Do I know my glucose and A1C numbers? Identify and manage prediabetes or diabetes with your healthcare professional.
□ HIGH BLOOD PRESSURE — Do I know my blood pressure? Uncontrolled hypertension can damage blood vessels throughout the body, including the brain.
□ HIGH CHOLESTEROL — Have I checked my LDL cholesterol? Elevated LDL in midlife is an important potentially modifiable dementia risk factor.
□ OBESITY — Am I maintaining a healthy body weight and addressing metabolic problems associated with excess body fat?
□ POOR DIET — Am I eating mostly nutritious foods, or relying heavily on processed foods, excessive sugar, and unhealthy fats?
□ INADEQUATE SLEEP — Am I getting sufficient, good-quality sleep? Have I investigated possible sleep apnea?
□ SMOKING — Do I smoke or use tobacco products? Quitting is one of the most important steps for cardiovascular and overall health.
□ EXCESSIVE ALCOHOL — Am I drinking heavily or frequently enough to damage my long-term health?
□ HEARING LOSS — Am I ignoring difficulty hearing conversations? Get your hearing evaluated and use hearing aids if recommended.
□ VISION PROBLEMS — Am I neglecting eye examinations or leaving treatable vision loss uncorrected?
□ SOCIAL ISOLATION — Am I spending too much time alone without meaningful contact with friends, family, or community?
□ DEPRESSION — Am I dealing with persistent depression without appropriate treatment or support?
□ LACK OF MENTAL STIMULATION — Am I continuing to learn, read, solve problems, develop skills, and challenge my brain?
□ HEAD INJURIES — Am I protecting myself against falls, traffic injuries, and repeated head impacts?
□ AIR POLLUTION — Am I unnecessarily exposing myself to smoke, exhaust, or other sources of harmful air pollution?
□ IGNORING MEDICAL CONDITIONS — Am I putting off routine health visits or failing to manage cardiovascular and metabolic conditions?
□ WAITING TOO LONG — Am I assuming that because I’m only 30, 40, or 50, I don’t need to think about long-term brain health?
Some of these risks are easier to change than others.
Nobody can simply decide to stop having depression, hearing loss, or diabetes.
And environmental problems such as air pollution require broader community and government action.
The point is to identify problems early and address them using whatever effective treatments, professional support, and lifestyle changes are available.
And remember, dementia risk reduction is not about blaming people who develop the disease.
Even with excellent prevention efforts, some people will still develop Alzheimer’s or another dementia.
WHAT I TAKE AWAY FROM ALL THIS
For years, people looked at Alzheimer’s as something that happened when you got old.
If it ran in your family, you worried about it.
If you developed symptoms, you went to the doctor.
And if you received the diagnosis, there were very limited treatment options.
That approach is beginning to change.
We now understand that vascular health, metabolic health, inflammation, physical activity, and many other factors may influence the development of dementia.
We have evidence that addressing modifiable risk factors could potentially prevent or delay a substantial proportion of dementia cases.
We have clinical trials investigating new biological targets and medications already used for other diseases.
And we have randomized research demonstrating that structured lifestyle interventions can improve cognitive performance.
We also have medications that can modestly slow the progression of early Alzheimer’s in selected patients.
None of this amounts to a cure. But compared with what we understood even a couple of decades ago, it represents meaningful progress.
And for people whose families have been affected by Alzheimer’s, that progress matters.
MY FINAL THOUGHT
When I think about my mother and Alzheimer’s, I can’t help wondering what might have been different if we had understood some of these things decades ago.
Would anything have changed?
I don’t know. And I would never pretend that eating better, exercising, or taking care of your health guarantees that you won’t develop Alzheimer’s.
It doesn’t. But if researchers are telling us that a substantial portion of dementia risk might be reduced through actions we can begin taking today, why would we ignore that information?
We spend enormous amounts of money maintaining our homes, repairing our cars, and protecting our financial investments.
Yet many people spend almost no time thinking about maintaining the one thing that makes all of those other things meaningful.
Their brain.
If you’re 30, start now.
If you’re 40, start now.
If you’re 60 or 70, there are still reasons to improve your health.
The earlier you begin, the more years you have to benefit.
You may not be able to control everything about your future.
But you can make choices today that improve the odds of remaining healthy, independent, and mentally engaged as you get older.
And if those choices also reduce your risk of Alzheimer’s and dementia, that is an extraordinary return on a relatively modest investment.
Perhaps the most important change in our understanding of Alzheimer’s is this:
We are no longer limited to asking how to treat a damaged brain. We are also learning how to protect a healthy one.
And that, to me, is genuinely good news.
The purpose of this article is to share research and encourage informed discussion, not to provide personal medical advice. Alzheimer’s is a complex disease, and no lifestyle program, supplement, or medication can guarantee prevention. Discuss your individual risk factors, family history, screening, and treatment decisions with qualified healthcare professionals.
Don’t believe me… What this video, it is one of the ones I used to make this post.
© 2026 insearchofyourpassions.com - Some Rights Reserve - This website and its content are the property of YNOT. This work is licensed under a Creative Commons Attribution 4.0 International License. You are free to share and adapt the material for any purpose, even commercially, as long as you give appropriate credit, provide a link to the license, and indicate if changes were made.







